1 |
张雅敏,朱志军,沈中阳. ABO血型不符患者的肝移植[J]. 中华危重病急救医学,2006, 18(7):439-440.
|
2 |
朱世凯,许甜. ABO血型不合肝移植的现状和最新进展[J]. 世界华人消化杂志,2017, 25(30):2665-2671.
|
3 |
Peters TG, Williams JW, HaRbmon HC, et al. Splenectomy and death in renal transplant patients[J]. Arch Surg, 1983, 119(4):795-799.
|
4 |
Ito K, Akamatsu N, Ichida A, et al. Splenectomy is not indicated in living donor liver transplantation[J]. Liver Transpl, 2016, 22(11):1526-1535.
|
5 |
Lee EC, Kim SH, Shim JR, et al. A comparison of desensitization methods: rituximab with/without plasmapheresis in ABO-incompatible living donor liver transplantation[J]. Hepatobiliary Pancreat Dis Int, 2018, 17(2):119-125.
|
6 |
Shen T, Lin BY, Jia JJ, et al. A modified protocol with rituximab and intravenous immunoglobulin in emergent ABO-incompatible liver transplantation for acute liver failure[J]. Hepatobiliary Pancreat Dis Int, 2014, 13(4):395-401.
|
7 |
Kim SH, Lee EC, Shim JR, et al. A simplified protocol using rituximab and immunoglobulin for ABO-incompatible low-titer living donor liver transplantation[J]. Liver Int, 2017, 42(4):697-707.
|
8 |
Yamamoto H, Uchida K, Kawabata S, et al. Feasibility of monotherapy by rituximab without additional dsensitization in ABO-incompatible living donor liver transplantation[J]. Transplantation, 2017, 102(1):97-104.
|
9 |
Egawa H, Teramukai S, Haga H, et al. Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study[J]. Am J Transplant, 2014, 14(1):102-114.
|
10 |
Honda M, Sugawara Y, Kadohisa M, et al. Long-term outcomes of ABO-incompatible pediatric living donor liver transplantation[J]. Transplantation, 2018. [Epub ahead of print]
|
11 |
Kim JM, Kwon CH, Joh JW, et al. Case-matched comparison of ABO-incompatible and ABO-compatible living donor liver transplantation[J]. Br J Surg, 2016, 103(3):276-283.
|
12 |
王玥. ABO血型不符肝移植的临床研究[D]. 天津:天津医科大学,2016.
|
13 |
Kim JM, Kwon CHD, Joh JW, et al. ABO-incompatible living donor liver transplantation with rituximab and total plasma exchange does not increase hepatocellular carcinoma recurrence[J]. Transplantation, 2018. [Epub ahead of print]
|
14 |
Lee J, Lee JG, Lee JJ, et al. Results of ABO-incompatible liver transplantation using a simplified protocol at a single institution[J]. Transplant Proc, 2015, 47(3):723-726.
|
15 |
Song GW, Lee SG, Hwang S, et al. ABO-incompatible adult living donor liver transplantation under the desensitization protocol with rituximab[J]. Am J Transplant, 2016, 16(1):157-170.
|
16 |
Skogsberg U, Breimer ME, Friman S, et al. Adult ABO-incompatible liver transplantation, using A and B donors[J]. Xenotransplantation, 2006, 13(2):154-159.
|
17 |
Szczeklik W, Wawrzycka K, Wudarczyk A, et al. Complications in patients treated with plasmapheresis in the intensive care unit[J]. Anaesthesiol Intensive Ther, 2013, 45(1):7-13.
|
18 |
Takahashi K, Saito K, Nakagawa Y, et al. Mechanism of acute antibody-mediated rejection in ABO-incompatible kidney transplantation: which anti-A/anti-B antibodies are responsible, natural or de novo?[J]. Transplantation, 2010, 89(5):635-637.
|
19 |
Ikegami T, Taketomi A, Soejima Y, et al. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation[J]. Transplantation, 2009, 88(3):303-307.
|
20 |
Magee CC. Transplantation across previously incompatible immunological barriers[J].Transpl Int, 2010, 19(2):87-97.
|
21 |
Egawa H, Teramukai S, Haga H, et al. Present status of ABO-incompatible living donor liver transplantation in Japan[J]. Hepatology, 2010, 47(1):143-152.
|
22 |
Raut V, Mori A, Kaido T, et al. Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab[J]. Transplantation, 2012, 93(1):99-105.
|
23 |
孙忠权. 美罗华时代ABO血型不符心脏死亡供肝肝移植的预后评价[D]. 杭州:浙江大学,2016.
|